Indeed, WT1 TED2 split, and to a lesser extent WT1 TED and WT1 TED2 tandem, elicited robust cytotoxicity against primary AML cells (Figure 4A; Supplementary Table 2). Here, WT1 is linked to acute myeloid leukemia.